What is PYPD's current stock price?

PYPD (PolyPid Ltd.) is currently trading at $5.02 with a market cap of $51.2M.

What sector is PolyPid Ltd. in?

PolyPid Ltd. (PYPD) operates in the Healthcare sector, specifically in the Biotechnology industry.

Is PYPD a good stock to buy?

Analysts have a Buy consensus on PYPD with a price target of $9.50. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

PYPD PolyPid Ltd.

Healthcare

$5.02+3.93%ClosedMarket Cap: $51.2M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

12.54

P/S

0.00

EV/EBITDA

-1.36

DCF Value

$0.12

FCF Yield

0.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-242.0%

ROA

-175.5%

ROIC

-114.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-7.7M	$—
Q4 null	$0.00	$-8.5M	$—
FY null	$0.00	$-34.2M	$—
Q3 null	$0.00	$-7.5M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$9.50

Target (Median)

$9.50

Target Range

$9.00 - $10.00

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-02-11

Roth CapitalBuy

2025-11-13

Craig-HallumBuy

2025-08-14

HC Wainwright & Co.Buy

2025-08-13

Roth CapitalBuy

2025-06-18

Trading Activity

Insider Trades

View All

Stein Robert Benjamindirector

SellMon Apr 06

Stein Robert Benjamindirector

SellMon Apr 06

Stein Robert Benjamindirector

SellMon Apr 06

Jacobovitz Yitzchak Shlomodirector:

SellMon Apr 06

Warshavsky Oriofficer: Chief Operating Officer - US

SellThu Mar 26

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

1.41

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Peers